Recursion Pharmaceuticals
clinical finalize design of a phase enriched trial initiate phase trial in select tumor types in early identify suitable partners for genetic testing capabilities evaluate in combination with targeted and or immune modulating agents next steps | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
118 of 143
Related slides by other companies
GH Research
Investor Presentation
May 2023
phase clinical pharmacology trial in healthy volunteers completed | GH Research
GH Research
Investor Presentation
March 2023
phase clinical pharmacology trial in healthy volunteers completed | GH Research
GH Research
Investor Presentation
November 2023
phase clinical pharmacology trial in healthy volunteers completed | GH Research
GH Research
Investor Presentation
March 2023
phase trial in treatment resistant depression completed | GH Research
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io